Ryan J. Watts

Insider Reports History

Entity
Individual
Location
C/O Denali Therapeutics Inc., 151 Oyster Point Blvd., 2 Nd Floor, South San Francisco, CA
Signature
/s/ Tyler Nielsen, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ryan J. Watts:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Denali Therapeutics Inc. President and CEO, Director Common Stock 2.2M $54.6M $24.78 Aug 20, 2024 Indirect
Denali Therapeutics Inc. President and CEO, Director Common Stock 236K $5.61M $23.79 Aug 20, 2024 Direct
Denali Therapeutics Inc. President and CEO, Director Stock Option (right to buy) 269K Jan 3, 2024 Direct

Insider Reports Filed by Ryan J. Watts

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DNLI Denali Therapeutics Inc. Aug 20, 2024 1 -$53.8K 4 Aug 22, 2024 President and CEO, Director
DNLI Denali Therapeutics Inc. Mar 29, 2024 1 $0 4 Mar 29, 2024 President and CEO, Director
DNLI Denali Therapeutics Inc. Feb 13, 2024 1 -$166K 4 Feb 15, 2024 President and CEO, Director
DNLI Denali Therapeutics Inc. Jan 9, 2024 1 -$155K 4 Jan 11, 2024 President and CEO, Director
DNLI Denali Therapeutics Inc. Jan 5, 2024 1 -$340K 4 Jan 9, 2024 President and CEO, Director
DNLI Denali Therapeutics Inc. Jan 3, 2024 2 $0 4 Jan 5, 2024 President and CEO, Director
DNLI Denali Therapeutics Inc. Aug 21, 2023 1 -$52.2K 4 Aug 23, 2023 President and CEO, Director
DNLI Denali Therapeutics Inc. Aug 10, 2023 3 -$61.5K 4 Aug 14, 2023 President and CEO, Director
DNLI Denali Therapeutics Inc. Jun 16, 2023 3 -$1.54M 4 Jun 20, 2023 President and CEO, Director
DNLI Denali Therapeutics Inc. Apr 20, 2023 6 -$612K 4 Apr 24, 2023 President and CEO, Director
DNLI Denali Therapeutics Inc. Feb 13, 2023 4 -$1M 4 Feb 15, 2023 President and CEO, Director
DNLI Denali Therapeutics Inc. Feb 9, 2023 4 -$816K 4 Feb 13, 2023 President and CEO, Director
DNLI Denali Therapeutics Inc. Jan 5, 2023 1 -$137K 4 Jan 9, 2023 President and CEO, Director
DNLI Denali Therapeutics Inc. Jan 3, 2023 3 -$144K 4 Jan 5, 2023 President and CEO, Director
DNLI Denali Therapeutics Inc. Aug 19, 2022 1 -$79.9K 4 Aug 23, 2022 President and CEO, Director
DNLI Denali Therapeutics Inc. Feb 11, 2022 1 -$330K 4 Feb 15, 2022 President and CEO, Director
DNLI Denali Therapeutics Inc. Feb 9, 2022 5 $298K 4 Feb 11, 2022 President and CEO, Director
DNLI Denali Therapeutics Inc. Jan 5, 2022 1 -$224K 4 Jan 7, 2022 President and CEO, Director
DNLI Denali Therapeutics Inc. Jan 3, 2022 2 $0 4 Jan 5, 2022 President and CEO, Director
DNLI Denali Therapeutics Inc. Dec 1, 2021 3 -$824K 4 Dec 3, 2021 President and CEO, Director
DNLI Denali Therapeutics Inc. Nov 1, 2021 2 -$912K 4 Nov 3, 2021 President and CEO, Director
DNLI Denali Therapeutics Inc. Oct 1, 2021 3 -$924K 4 Oct 5, 2021 President and CEO, Director
DNLI Denali Therapeutics Inc. Sep 1, 2021 2 -$1M 4 Sep 3, 2021 President and CEO, Director
DNLI Denali Therapeutics Inc. Aug 19, 2021 2 -$118K 4 Aug 23, 2021 President and CEO, Director
DNLI Denali Therapeutics Inc. Aug 2, 2021 2 -$942K 4 Aug 4, 2021 President and CEO, Director
DNLI Denali Therapeutics Inc. Jul 1, 2021 3 -$1.42M 4 Jul 6, 2021 President and CEO, Director
DNLI Denali Therapeutics Inc. Jun 1, 2021 4 -$1.13M 4 Jun 3, 2021 President and CEO, Director